Skip to content
MedsAcross

Medicine

Soolantra 1% cream

Ivermectin · Topical · Galderma Laboratories
Available on requestPrescription onlyUS FDA

Soolantra 1% cream is a prescription medicine containing Ivermectin for topical use, marketed by Galderma Laboratories, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and…

Key facts

Active ingredient (INN)
Ivermectin
Brand
Soolantra
Strength
1%
Dosage form
Cream
Route
Topical
Packs
1 tube
Marketing authorisation holder
Galderma Laboratories
Manufacturer
Galderma Laboratories
Origin register
US FDA, United States
Storage
Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
D11AX22 Ivermectin
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 January 2015
Identifiers
RxCUI 1598068, 1598073DailyMed set ID b1d5b166-ab06-4ab5-b0c6-31126238118aNDC 0299-3823Application NDA206255

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 tube in 1 carton / 30 g in 1 tube0299-3823-30Galderma Laboratories1 January 2015
1 tube in 1 carton / 45 g in 1 tube0299-3823-45Galderma Laboratories1 January 2015
1 tube in 1 carton / 60 g in 1 tube0299-3823-60Galderma Laboratories1 January 2015

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 22 November 1996Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Ivermectin 1% cream.

Compare 1

Other strengths and forms of Ivermectin

Clinical summary

Ivermectin is an antiparasitic indicated for the treatment of infections, among other approved uses. It is available as tablets and cream for oral and topical use. MedsAcross supplies Ivermectin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Ivermectin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Soolantra 1% cream for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.